Summary | Bottom line: China job cuts at GSK and Tesla reflect
broader adjustments that major multinationals are making as
Beijing cleans up its business climate and fails to meet many
of its aggressive targets for new sectors. Two high-profile
multinationals are slimming down in China, with word that
British drug giant GlaxoSmithKline (London: GSK) and US ...
youngchinabiz.com | 05 April 2016